Centene Co. (NYSE:CNC) Shares Acquired by Seizert Capital Partners LLC

Seizert Capital Partners LLC increased its holdings in shares of Centene Co. (NYSE:CNC) by 6.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 112,141 shares of the company’s stock after purchasing an additional 6,564 shares during the quarter. Seizert Capital Partners LLC’s holdings in Centene were worth $8,442,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in CNC. Park Place Capital Corp lifted its position in shares of Centene by 1,190.0% during the 3rd quarter. Park Place Capital Corp now owns 387 shares of the company’s stock worth $29,000 after buying an additional 357 shares during the last quarter. WR Wealth Planners LLC boosted its stake in Centene by 41.4% in the second quarter. WR Wealth Planners LLC now owns 468 shares of the company’s stock valued at $31,000 after acquiring an additional 137 shares in the last quarter. Chris Bulman Inc purchased a new position in shares of Centene during the second quarter worth about $33,000. Riverview Trust Co increased its position in shares of Centene by 154.6% during the second quarter. Riverview Trust Co now owns 527 shares of the company’s stock worth $35,000 after purchasing an additional 320 shares in the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. purchased a new stake in shares of Centene in the 2nd quarter valued at about $36,000. 93.63% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Centene

In related news, CFO Andrew Lynn Asher bought 17,200 shares of the stock in a transaction that occurred on Wednesday, November 13th. The stock was purchased at an average cost of $58.14 per share, for a total transaction of $1,000,008.00. Following the completion of the acquisition, the chief financial officer now owns 486,847 shares in the company, valued at $28,305,284.58. This trade represents a 3.66 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Sarah London purchased 4,117 shares of Centene stock in a transaction on Friday, November 8th. The shares were acquired at an average cost of $60.80 per share, for a total transaction of $250,313.60. Following the completion of the transaction, the chief executive officer now owns 667,229 shares of the company’s stock, valued at $40,567,523.20. This represents a 0.62 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Company insiders own 0.33% of the company’s stock.

Centene Price Performance

Shares of CNC opened at $57.46 on Friday. The firm has a market capitalization of $29.01 billion, a PE ratio of 9.98, a P/E/G ratio of 0.80 and a beta of 0.49. The stock’s 50 day moving average is $68.06 and its two-hundred day moving average is $71.00. Centene Co. has a twelve month low of $57.25 and a twelve month high of $81.42. The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 0.64.

Wall Street Analyst Weigh In

CNC has been the topic of several research analyst reports. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $90.00 price target on shares of Centene in a research report on Tuesday, October 1st. Oppenheimer cut their target price on shares of Centene from $110.00 to $95.00 and set an “outperform” rating on the stock in a report on Monday, July 29th. TD Cowen increased their price target on shares of Centene from $80.00 to $89.00 and gave the stock a “buy” rating in a research note on Wednesday, July 31st. Sanford C. Bernstein dropped their price objective on shares of Centene from $96.00 to $88.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 30th. Finally, StockNews.com downgraded shares of Centene from a “strong-buy” rating to a “buy” rating in a research note on Monday, October 28th. Seven analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $83.92.

Centene Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.